Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA

DOI: 10.4143/crt.2018.070

Keywords: Biomarkers, Macrophage migration inhibitory factor, Chemokine CCL3, Nasopharyngeal carcinoma, Diagnosis, Microarray

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text